Artemis Hospitals
| India | Turkey | Austria | |
| Plasmapheresis | from $4,200 | from $1,200 | from $2,000 |
| Ocrevus (ocrelizumab) | from $18,200 | from $10,000 | from $35,000 |
| Multiple sclerosis rehabilitation | from $3,200 | from $3,000 | from $10,000 |
| Medication treatment for multiple sclerosis | from $3,200 | from $2,500 | from $2,000 |
| Therapeutic Apheresis | from $850 | from $1,350 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Multiple sclerosis treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Multiple sclerosis treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Multiple sclerosis treatment journey.
With 33 years of professional experience, the doctor is an accomplished Indian neurosurgeon known for international training and innovative treatment methodologies. The doctor has numerous scientific publications and public speaking engagements.
Graduating from Madras University, further postgraduate training was undertaken at KRH Klinikum Nordstadt in Germany and University Hospital of Zürich in Switzerland.
The doctor serves as the Director of the Institute of Neurosciences and Spinal Disorders and is a Senior Consultant Neurosurgeon at Global Hospital. Notable inventions include the Spinal Retractor System and the Occipito-Cervical Plate Screw Wire Construct.
The doctor has been the Head of Liver Transplant and Hepato-Biliary Surgery at Gleneagles Global Hospitals Mumbai since 2014, with over 20 years of experience in transplantation from both living and cadaver donors.
Specializing in liver, pancreas, intestinal, and multivisceral transplants for adults and children, the doctor has performed over 1,300 transplants with a patient survival rate of 88%. They utilize advanced techniques such as laparoscopic and robotic surgeries.
The doctor has published 35 scientific articles and 5 book chapters and has worked in leading hospitals across the USA, India, France, and Italy.
Multiple Sclerosis is treatable in India through advanced disease-modifying therapies and specialized neuro-rehabilitation. Leading JCI-accredited centers in Delhi, Mumbai, and Bengaluru offer modern infusions like Ocrelizumab. Treatment focus remains on managing relapses and slowing progression using international medical protocols and diagnostic imaging.
Bookimed Expert Insight: While many believe specialized care is limited to the capital, Manipal Hospitals in Bengaluru serves 2 million patients annually across a massive 15-hospital network. This scale allows them to maintain consistent stocks of newer disease-modifying therapies that are often unavailable in smaller regional centers.
Patient Consensus: Patients emphasize that getting diagnosed in major metropolitan hospitals is faster than in government facilities. Many note the importance of joining support groups to find affordable generic medication suppliers and active clinical trials.
Advanced Multiple Sclerosis treatments like Hematopoietic Stem Cell Transplantation (HSCT) in India show success rates between 80% and 90% for halting disease progression. Outcomes are highest for Relapsing-Remitting Multiple Sclerosis (RRMS) patients. Indian centers utilize global auto-SCT protocols within Joint Commission International (JCI) accredited facilities.
Bookimed Expert Insight: While many focus on Delhi or Mumbai, Apollo Hospital Indraprastha in Delhi stands out as the largest transplantation center outside the USA. This high volume is a critical quality signal. Data shows centers performing more transplants typically manage post-chemotherapy recovery more effectively, which is vital for MS patients whose primary risk is infection during the 3-month recovery window.
Patient Consensus: Patients note that while the procedure is life-changing, intense chemotherapy side effects require strict isolation. Many emphasize tracking baseline MRI data carefully to measure long-term success accurately.
India offers advanced Multiple Sclerosis treatment at JCI-accredited facilities in Delhi, Mumbai, and Gurgaon. Leading centers like Artemis Hospitals and Apollo Hospital Indraprastha provide specialized neuroimaging, plasma exchange, and monoclonal antibody therapies. These hospitals integrate neurology with multidisciplinary rehabilitation for comprehensive patient care.
Bookimed Expert Insight: Patient volume data highlights a significant gap in service speed between private and public sectors. While AIIMS Delhi is a premier research center, private networks like Manipal Hospitals serve over 2,000,000 patients annually with significantly shorter wait times. Choosing a facility in the Manipal or Apollo network often ensures quicker access to critical infusions like Ocrevus compared to the typical 6-month wait in public institutions.
Patient Consensus: Patients note that private clinics in Mumbai and Bangalore offer faster access to diagnostic tests like evoked potentials. Many emphasize joining local support groups to find the most affordable pricing for high-quality generic medications.
India provides a diverse range of recognized complementary treatments through the Ministry of AYUSH. These therapies include Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homeopathy. While not curative for multiple sclerosis, they serve as adjunctive care to manage symptoms alongside conventional neurological treatments.
Bookimed Expert Insight: Patients often overlook that India's largest medical networks, such as Manipal or Apollo, provide access to 1,900+ doctors. This scale allows patients to combine advanced neurology with recognized alternative medicine in one city. Choosing a facility with both JCI and NABH accreditations ensures that complementary therapies meet international safety standards.
Patient Consensus: Patients emphasize that while Ayurveda and Yoga help significantly with mental health and mobility, they must never replace disease-modifying therapies. Many note that Vitamin D and B12 supplementation is essential in India due to high local deficiency rates.
The Indian government supports MS patients through the Rights of Persons with Disabilities Act 2016. This provides legal recognition and workplace protection. Patients can access subsidized care at AIIMS and through the Central Government Health Scheme. Financial aid primarily comes from state-specific welfare programs and NGOs.
Bookimed Expert Insight: While national drug subsidies are limited, top private centers like Manipal Hospitals and Apollo Indraprastha offer advanced diagnostics like MRI and CT. Private facilities often provide faster access to specialized neurologists like Dr. Hitesh Kumar. Patients at these JCI-accredited hubs can access multidisciplinary care that smaller government centers may lack.
Patient Consensus: Patients note that government aid is often patchy and mostly covers basic mobility aids. Many suggest applying for state disability certificates immediately to secure monthly pensions and potential medication discounts.